Enter B and W: two new meningococcal vaccine programmes launched - Wikidata - awgldk - TriplyDB

Enter B and W: two new meningococcal vaccine programmes launched

Enter B and W: two new meningococcal vaccine programmes launched

http://www.wikidata.org/entity/Q26775667

about

Emerging experience with meningococcal serogroup B protein vaccines.Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?The importance of surveillance: Group W meningococcal disease outbreak response and control in England.Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity.Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?The next chapter for group B meningococcal vaccines.Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016.Novel approaches to Neisseria meningitidis vaccine design.Validation of two algorithms for managing children with a non-blanching rash.Meningococcal W outbreak.Community-acquired bacterial meningitis.Meningococcal arthritis and myopericarditis: a case report.4CMenB vaccine effectiveness: reasons for optimism.Challenges and opportunities for Meningococcal vaccination in the developing world.Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010-2016.Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.

P2860

Q30234958-D758A6D2-BB17-4E93-9682-38EA995F4DF7 Q30235138-A5FCED88-291E-4513-A2FA-BF8794AAE091 Q30245411-15C15F2A-BD72-4041-9E66-B78391E2726B Q33703622-4BE8B271-FE13-4D09-8DA9-3BFE9D7B8F96 Q37483629-F7620DB1-075D-4F1F-A4B2-785983B36F05 Q38674983-16457AFA-7E21-41DE-9372-E1EC42709BA9 Q38677309-42A3A836-EF1B-4EBB-9D9E-AEE0C8D0E16B Q38795433-100E32C0-A54C-4002-9C16-1DC6C3A3A90B Q39215403-F180F55D-F3BD-4275-85E4-DCB6958CC624 Q39914565-162FF6BE-2F45-4DBF-A73D-92C72A277FD6 Q40657029-E9CD46BE-44ED-46E5-98F3-9F17349E8572 Q43568749-A8D2944C-A7F6-409C-8F3F-C352E3C6547F Q47097240-C8F6C1B6-5A88-47A8-B346-0FDCA2A5C8CE Q47352260-BD44CB56-9AA7-4A50-B6F9-3A2F4B21EE3E Q49377063-16536AE0-0272-4420-8662-07E6853DA4DE Q54956641-C2AF4645-B325-4813-BAE0-21DABEEDDF66 Q55154523-74297FF4-8734-4C1D-A9B9-8916C396844B

P2860

Enter B and W: two new meningococcal vaccine programmes launched

http://www.wikidata.org/entity/Q26775667

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Enter B and W: two new meningococcal vaccine programmes launched

@ast

Enter B and W: two new meningococcal vaccine programmes launched

@en

Enter B and W: two new meningococcal vaccine programmes launched

@nl

type

label

Enter B and W: two new meningococcal vaccine programmes launched

@ast

Enter B and W: two new meningococcal vaccine programmes launched

@en

Enter B and W: two new meningococcal vaccine programmes launched

@nl

prefLabel

Enter B and W: two new meningococcal vaccine programmes launched

@ast

Enter B and W: two new meningococcal vaccine programmes launched

@en

Enter B and W: two new meningococcal vaccine programmes launched

@nl

P1433

Q26775667-CA2F189B-51BE-4EC9-82F8-887BFEE2188A

P1476

Q26775667-8257CAEB-831C-430B-96DA-009E16B68D67

P2093

Q26775667-087068B7-C92E-4AB2-96EE-11B21D2E4932

Q26775667-7B568BCD-9CFC-4BA5-BA32-BFE686572C53

Q26775667-96D7F48B-E671-469D-AD25-599952C8CF5D

Q26775667-BF877778-5F91-4D40-9C03-5BDF25976750

P275

Q26775667-89791CFD-A3E8-4545-B612-48FCDC1A4431

P2860

Q26775667-044B0EF0-F9A6-4414-927F-10056D574A0E

Q26775667-0A15D481-D1AC-4205-BC19-A16FC6F310B7

Q26775667-13EDA13A-B120-44C5-AE38-02B5B563D2B4

Q26775667-38A843C2-5311-4CAC-A2E2-FD214CA7BC05

Q26775667-49285821-81C8-4E01-8098-A646CA293EFC

Q26775667-51673012-379A-48CB-A14F-3132482222C2

Q26775667-74ABC42B-EA83-4462-8AFA-045DFD4FBE29

Q26775667-76C27942-8902-4AE3-8B76-0D73FDDAE077

Q26775667-79356FC0-4664-47F1-9D0E-D9B28E05D0F1

Q26775667-835099ED-85EB-489E-9DE7-161BEED48641

P304

Q26775667-05EF1EC5-22BC-4787-9829-CEE892F3965F

P31

Q26775667-4D233916-AA5E-4800-9BF8-C5608AA430AD

P356

Q26775667-8EBAF1D4-9639-4553-AC1A-65869075664A

P407

Q26775667-1C394AF7-41CA-482C-A443-F739F13FD617

P433

Q26775667-50975DAD-03A0-48F0-BCB6-1E38178A6546

P478

Q26775667-6F637FD2-6487-47AB-9A4F-479FB66859DA

P50

Q26775667-60A7D3B4-2247-49DA-A04B-311A62EC62D4

Q26775667-E1ECE515-657B-453B-935E-0739E51DA975

P577

Q26775667-DE74EF54-0E00-4043-A34C-8336979AFA2C

P5875

Q26775667-C3849B21-2ED2-48F8-92FF-51C7ABB6EE29

P698

Q26775667-BCF9BFED-A8A1-4EA5-BE64-2F30A29149FC

P921

Q26775667-4DD3DF10-4AE0-47AF-A71E-AE5DE2D8276D

Q26775667-D84A16E6-4C96-415D-A8DB-E6C1528E6635

P932

Q26775667-E0042E64-15FC-409B-8A1E-4F4BBDD1E994

P356

ARCHDISCHILD-2015-308928

P1433

Archives of Disease in Childhood

P1476

Enter B and W: two new meningococcal vaccine programmes launched

@en

P2093

Andrew J Pollard

http://www.w3.org/2001/XMLSchema#string

Andrew Riordan

http://www.w3.org/2001/XMLSchema#string

John M Watson

http://www.w3.org/2001/XMLSchema#string

Ray Borrow

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Meningococcal carriage by age: a systematic review and meta-analysis.

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).

Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study.

Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.

Advances in the development of vaccines against Neisseria meningitidis.

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

P304

91-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARCHDISCHILD-2015-308928

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Shamez N Ladhani

Mary Elizabeth Ramsay

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287203425

http://www.w3.org/2001/XMLSchema#string

P698

26672098

http://www.w3.org/2001/XMLSchema#string

P921

preventive health services

obstetrics and gynaecology

P932

4717420

http://www.w3.org/2001/XMLSchema#string